Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity

The development of effective malaria vaccines remains a global health priority. Currently, the most advanced vaccine, known as RTS,S, has only shown modest efficacy in clinical trials. Thus, the development of more efficacious vaccines by improving the formulation of RTS,S for increased efficacy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jo-Anne, Wetzel, David, Reiling, Linda, Miura, Kazutoyo, Drew, Damien R., Gilson, Paul R., Anderson, David A., Richards, Jack S., Long, Carole A., Suckow, Manfred, Jenzelewski, Volker, Tsuboi, Takafumi, Boyle, Michelle J., Piontek, Michael, Beeson, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736250/
https://www.ncbi.nlm.nih.gov/pubmed/31504038
http://dx.doi.org/10.1371/journal.pone.0221733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736250/
https://www.ncbi.nlm.nih.gov/pubmed/31504038
http://dx.doi.org/10.1371/journal.pone.0221733

Ejemplares similares